Lu, IN
Bo Lu, Westfield, IN US
Patent application number | Description | Published |
---|---|---|
20090268414 | Over-molded electronic module - An over-molded electronic module ( | 10-29-2009 |
20100192698 | SEAT SENSOR APPARATUS FOR OCCUPANT PRESENCE DETECTION - An occupant presence sensor apparatus disposed in a seat includes first and second substantially non-compliant force translation plates generally parallel to the seating surface of the seat, an elastomeric mat disposed between the first and second force translation plates, and a switch mechanism disposed between the first and second force translation plates within an opening formed in the elastomeric mat. The elastomeric mat includes a distributed array of hollow protuberances that extend toward and contact the force translation plates, and the mat has a stiffness that normally provides a clearance between the switch mechanism and one of the force translation plates. When an occupant of specified or higher weight sits on the seating surface, the protuberances collapse and the force translation plates activate the switch mechanism. | 08-05-2010 |
20100198464 | DIAGNOSABLE MAGNETIC SWITCH ASSEMBLY - A diagnosable magnetic switch assembly and method for determining a seat occupant. A network in the assembly includes a resistor in series with a magnetic switch, and a resistor in parallel with the series combination. Such an arrangement provides distinct assembly resistance values when the magnetic switch is open or closed, and thereby provides a means for diagnosing the operational state of the diagnosable magnetic switch assembly. The diagnosable magnetic switch assembly may be included in a seat occupant indicator system that embeds the seat occupant indicator system and a magnet in a cushion of a seat assembly. When the seat assembly is occupied, the magnet is separated from the seat occupant indicator system by a sufficient distance so the seat occupant indicator system is in an open state. When an occupant sits in the seat assembly, the magnet and the seat occupant indicator system are brought closer together so that the magnetic field operate the seat occupant indicator system to a closed state. A controller measures the assembly resistance values to determine if the seat assembly is empty, occupied, or if an assembly fault state is occurring. | 08-05-2010 |
Chang Lu, West Lafayette, IN US
Patent application number | Description | Published |
---|---|---|
20100221769 | ELECTROPORATIVE FLOW CYTOMETRY - Novel devices and methods are provided, which include electroporative flow cytometry, where electroporation is combined with flow cytometry. The devices and methods can be used for the detection a variety of cellular features, including protein translocation, and for monitoring biomechanics at single cell level. Using the novel devices methods it is possible to observe the release of proteins such as intracellular kinases out of the cells during electroporation. Using the novel devices methods it is possible to study cytoskeleton dynamics and deformability at a single cell level, and to correlate these to diseases such as cancers. | 09-02-2010 |
Chao Lu, West Lafayette, IN US
Patent application number | Description | Published |
---|---|---|
20110260536 | Efficient Power Conversion for Ultra Low Voltage Micro Scale Energy Transducers - A power converter is provided for an energy harvesting system of a micro-scale electronic device. The power converter is configured to transfer electrical energy from an energy transducer to an energy storage device. The power converter illustratively includes a tree topology charge pump. | 10-27-2011 |
20120182518 | Variation-Tolerant Self-Repairing Displays - Illustrative embodiments of systems and methods for variation-tolerant, self-repairing displays are disclosed. In one illustrative embodiment, a display panel may include one or more defective pixels and a compensation circuit may be configured to extend a charging time of each of the one or more defective pixels. In another illustrative embodiment, a method may include detecting one or more defective pixels in a pixel array and extending a charging time of each of the one or more defective pixels. | 07-19-2012 |
Fang Lu, Westfield, IN US
Patent application number | Description | Published |
---|---|---|
20120117681 | SOYBEAN MARKERS LINKED TO SCN RESISTANCE - This disclosure concerns compositions and methods for identifying the SCN resistant phenotype in soybean. In some embodiments, the disclosure concerns methods for performing marker-assisted breeding and selection of plants carrying one or more determinants of SCN resistance in soybean. | 05-10-2012 |
20120131693 | SOYBEAN MARKERS LINKED TO SCN RESISTANCE - This disclosure concerns compositions and methods for identifying the SCN resistant phenotype in soybean. In some embodiments, the disclosure concerns methods for performing marker-assisted breeding and selection of plants carrying one or more determinants of SCN resistance in soybean. | 05-24-2012 |
20140283197 | SOYBEAN MARKERS LINKED TO PHYTOPHTHORA RESISTANCE - This disclosure concerns compositions and methods for identifying the | 09-18-2014 |
Henry Lu, Westfield, IN US
Patent application number | Description | Published |
---|---|---|
20110149277 | Multi-Layer Slides for Analysis of Urine Sediments - Visual analysis of urine samples is carried out with the use of a slide consisting of three layers containing an enclosed viewing chamber which receives a urine sample deposited by pipette into an opening on the outer layer of the slide. From the inlet opening the sample enters an inlet chamber in the middle layer and passes through a capillary passageway into the viewing chamber where it is inspected for particles and sediments. | 06-23-2011 |
Henry Lu, Bloomington, IN US
Patent application number | Description | Published |
---|---|---|
20130041236 | SAMPLE ANALYSIS SYSTEM AND METHOD OF USE - A sample collection device having a sample container and microfluidic device having one or more microfluidic circuits, the system for analyzing biological samples. The microfluidic device has a sample inlet port, a microconduit in communication with the inlet port and with reaction chamber. The reaction chamber is connected to an air vent via another microconduit. Air may be vented from the microfluidic circuit via the air vent of the microfluidic circuit via an air vent in the sample container. | 02-14-2013 |
Hui Lu, West Lafayette, IN US
Patent application number | Description | Published |
---|---|---|
20150043382 | HYBRID NETWORK MANAGEMENT - Method and systems for controlling a hybrid network having software-defined network (SDN) switches and legacy switches include initializing a hybrid network topology by retrieving information on a physical and virtual infrastructure of the hybrid network; generating a path between two nodes on the hybrid network based on the physical and virtual infrastructure of the hybrid network; generating a virtual local area network by issuing remote procedure call instructions to legacy switches in accordance with a network configuration request; and generating an SDN network slice by issuing SDN commands to SDN switches in accordance with the network configuration request. | 02-12-2015 |
Jianlaing Lu, Fishers, IN US
Patent application number | Description | Published |
---|---|---|
20100016350 | NOVEL MCH RECEPTOR ANTAGONISTS - The present invention relates to a melanin concentrating hormone antagonist compound of formula (I): wherein R | 01-21-2010 |
Jianliang Lu, Fishers, IN US
Patent application number | Description | Published |
---|---|---|
20080200552 | Vitamin D Receptor Modulators - The present invention relates to novel, non-secosteroidal, hydroxyl substituted, carbon-linked diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis. | 08-21-2008 |
20090018058 | Vitamin D Receptor Modulators - The present invention relates to novel, non-secosteroidal, diaryl compounds with vitamin D receptor (VDR) modulating and psoriasis. | 01-15-2009 |
20090093456 | NOVEL MCH RECEPTOR ANTAGONISTS - The present invention relates to a melanin concentrating hormone antagonist compound of formula (1): wherein R | 04-09-2009 |
20100076065 | VITAMIN D RECEPTOR MODULATORS - The present invention relates to novel, non-secosteroidal, phenyl-benzothiophene compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis. | 03-25-2010 |
20110144091 | Inhibitors of Diacylglycerol Acyltransferase - This invention provides compounds of formula I: | 06-16-2011 |
20120302547 | NOVEL MCH RECEPTOR ANTAGONISTS - The present invention relates to a melanin concentrating hormone antagonist compound of formula (I) wherein R | 11-29-2012 |
Jirong Lu, Carmel, IN US
Patent application number | Description | Published |
---|---|---|
20080269467 | Anti-IL-17 Antibodies - Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders. | 10-30-2008 |
20100015155 | PEGYLATED ABETA FAB - A method to treat conditions associated with Aβ peptide activity both prophylactically and therapeutically is described. The method employs humanized antibody fragments that specifically bind human Aβ peptide between amino acid positions 13-28, wherein the antibody fragments are covalently attached to a polyethylene glycol (PEG) molecule. | 01-21-2010 |
20100129369 | c-Met Antibodies - Provided are monoclonal antibodies, antigen-binding fragments thereof, and combinations of the foregoing, that bind to, and inhibit the activity of, c-Met, and that are effective in treating cancers and other diseases, disorders, or conditions where pathogenesis is mediated by c-Met. | 05-27-2010 |
20110027290 | ANTI-IL-17 ANTIBODIES - Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders. | 02-03-2011 |
20120263723 | c-Met Antibodies - Provided are monoclonal antibodies, antigen-binding fragments thereof, and combinations of the foregoing, that bind to, and inhibit the activity of, c-Met, and that are effective in treating cancers and other diseases, disorders, or conditions where pathogenesis is mediated by c-Met. | 10-18-2012 |
20130142806 | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF - The present invention provides anti-N3pGlu Aβ antibodies or antigen-binding fragment thereof. In addition, the present invention provides the use of the anti-N3pGlu Aβ antibodies or antigen-binding fragment thereof for the treatment of Alzheimers disease. | 06-06-2013 |
20130280256 | ANTI-BAFF-ANTI-IL-17 BISPECIFIC ANTIBODIES - Bispecific antibodies are provided that specifically bind B-cell Activating Factor of the TNF Family (BAFF) and Interleukin-17A (IL-17) and are characterized as having high affinity and strong neutralizing properties to both BAFF and IL-17. The bispecific antibodies of the invention are expected to be useful in treating Lupus Nephritis (LN), Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Psoriasis (Ps), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PA), primary Sjögren's Syndrome (pSS), or Multiple Myeloma (MM). | 10-24-2013 |
20130324474 | VARIANTS OF HUMAN GDNF - The present invention relates to novel variants of human glial cell-derived neurotrophic factor (GDNF) and methods for their use. | 12-05-2013 |
20140065138 | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF - The present invention provides anti-N3pGlu Aβ antibodies or antigen-binding fragment thereof. In addition, the present invention provides the use of the anti-N3pGlu Aβ antibodies or antigen-binding fragment thereof for the treatment of Alzheimer's disease. | 03-06-2014 |
20140255406 | ANTI-TNF-ANTI-IL-17 BISPECIFIC ANTIBODIES - Bispecific antibodies are provided that specifically bind both Tumor Necrosis Factor alpha (TNFα) and Interleukin-17 (IL-17). The bispecific antibodies of the invention are useful for treating various autoimmune diseases, including Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Ankylosing Spondylitis (AS). | 09-11-2014 |
20140349310 | Anti-c-Met Antibodies - Provided is a monoclonal antibody, or antigen-binding fragment thereof that binds to c-Met. Such antibodies, or antigen-binding fragments thereof, are useful in in vivo, ex vivo or in vitro immunochemical and other imaging methods for detecting cell surface c-Met receptor levels for diagnostic, prognostic and predictive purposes, and for optimizing therapeutic regimens in patients harboring tumors in which c-Met is implicated in pathogenesis. | 11-27-2014 |
20150118238 | Anti-c-Met Antibodies - The present invention relates to antibodies, or antigen-binding fragments thereof, that bind to the extracellular domain of human c-Met, compositions and kits comprising such c-Met antibodies, or antigen-binding fragments thereof, and methods of using the same for detection of human c-Met that aid in identifying patients with tumors expressing or overexpressing human Met and/or improving their treatment response with anti-c-Met therapeutics. | 04-30-2015 |
20150175708 | Multifunctional Antibodies Binding to EGFR and MET - Provided are multifunctional antibodies, and/or antigen-binding fragments, that bind to, and inhibit the activity of, both human epidermal growth factor receptor (EGFR) and MET, and that are effective in treating cancers and other diseases, disorders, or conditions where pathogenesis is mediated by EGFR and MET. | 06-25-2015 |
Jirong Lu, Indianapolis, IN US
Patent application number | Description | Published |
---|---|---|
20090209004 | HUMAN IL-1 BETA ANTAGONISTS - The present invention encompasses isolated antibodies, or antigen-binding portions thereof, that specifically bind mature human IL-1 Beta. These antibodies, or antigen-binding portions thereof, generally exhibit high binding affinities (low k | 08-20-2009 |
John Z. Lu, Kokomo, IN US
Patent application number | Description | Published |
---|---|---|
20090102723 | Dual moded stacked microstrip patch antenna - A dual moded stacked microstrip patch antenna includes an integrated first lower antenna element having probes excited at a higher transverse magnetic order mode and a second upper antenna element with probes excited at a lower order transverse magnetic mode. Distinct probe locations and phase offset signals are supplied to each of the probes in each of the first and second antenna elements to support the higher and lower order mode of operation. | 04-23-2009 |
Peng Lu, Bloomington, IN US
Patent application number | Description | Published |
---|---|---|
20120291675 | METHODS AND PRODUCTS UTILIZING MAGNESIUM OXIDE FOR CARBON DIOXIDE SEQUESTRATION - Provided are methods for sequestering carbon dioxide utilizing magnesium hydroxide. A recovery method and system for recovering a gaseous component is provided. Methods and systems may utilize an alkaline component produced by thermal activation of magnesium hydroxide. Compositions of sequestered carbon dioxide comprising magnesium carbonate or magnesium bicarbonate are provided. | 11-22-2012 |
20130195747 | CALCIUM SULFATE AND CO2 SEQUESTRATION - Systems, methods, and compositions are provided related to utilizing gypsum for CO | 08-01-2013 |
Peng-Cheng Lu, West Lafayette, IN US
Patent application number | Description | Published |
---|---|---|
20150299246 | N-SUBSTITUTED INDENOISOQUINOLINES AND SYNTHESES THEREOF - N-Substituted indenoisoquinoline compounds, and pharmaceutical formulations of N-substituted indenoisoquinoline compounds are described. Also described are processes for preparing N-substituted indenoisoquinoline compounds. Also described are methods for treating cancer in mammals using the described N-substituted indenoisoquinoline compounds or pharmaceutical formulations thereof. | 10-22-2015 |
Song Lu, Zionsville, IN US
Patent application number | Description | Published |
---|---|---|
20150083456 | CONDUCTIVE, VIBRATION DAMPENING ISOLATOR - The present invention is a conductive isolator including a damping structure, a conductive bridge component positioned within the damping structure, axial contact points between the damping structure and the conductive bridge component and radial contact points between the damping structure and the conductive bridge component. | 03-26-2015 |
Tian Lu, Osceola, IN US
Patent application number | Description | Published |
---|---|---|
20140268592 | Assembling and Handling Edge Interconnect Packaging System - Apparatuses and methods related to the field of microchip assembly and handling, in particular to devices and methods for assembling and handling microchips manufactured with solid edge-to-edge interconnects, such as Quilt Packaging® interconnect technology. Specialized assembly tools are configured to pick up one or more microchips, place the microchips in a specified location aligned to a substrate, package, or another microchip, and facilitate electrical contact through one of a variety of approaches, including solder reflow. This specialized assembly tooling performs heating functions to reflow solder to establish electrical and mechanical interconnections between multiple microchips. Additionally, the interconnected microchips may be arranged in an arbitrarily large array. | 09-18-2014 |
Xiao Lu, Zionsville, IN US
Patent application number | Description | Published |
---|---|---|
20090099211 | TREATMENTS FOR CONGESTIVE HEART FAILURE - Methods and pharmaceutical preparations for treating heart failure by administering to a human or animal subject a therapeutically effective amount of at least one substance selected from the group consisting of a) SOD mimics (e.g., Tempol), b) NADPH oxidase inhibitors (e.g., Apocynin) and c) other substance that inhibit or reduce the amount of superoxide present in the affected tissues (e.g., the subjects heart and/or blood vessels) and/or increase levels of nitric oxide. | 04-16-2009 |
20100222651 | DEVICES, SYSTEMS, AND METHODS FOR DETERMINING ISOMETRIC AND ISOTONIC ACTIVITY OF LUMINAL ORGANS - Devices, systems, and methods for determining isometric and isotonic activity of luminal organs. In an exemplary method for detecting a luminal organ response to mechanical stimulation of the present disclosure, the method comprises the steps of maintaining a luminal organ at a first internal pressure, increasing the first internal pressure of the luminal organ, and measuring a first organ parameter change in response to the increase in internal pressure. In an exemplary system for detecting a luminal organ response to mechanical stimulation of the present disclosure, the system comprises a first conduit having a proximal end, a distal end, and a lumen therethrough, the distal end sized and shaped to fit within a luminal organ, a pressure transducer, and at least one pressurized vessel capable of introducing a fluid into the lumen of the first conduit, wherein the first conduit, the pressure transducer, and the at least one pressurized vessel are either directly or indirectly coupled to one another so that a pressure of a fluid present within the first conduit can be measured using the pressure transducer. | 09-02-2010 |
20140378885 | INTESTINAL DEVICES AND METHODS FOR FACILITATING WEIGHT LOSS - Intestinal devices and methods for facilitating weight loss. In at least one embodiment of a method of patient treatment of the present disclosure, the method comprises the step of positioning a device, that is configured to reduce or limit localized intestinal distension, around a portion of an intestine of a patient. | 12-25-2014 |
Xiaofeng Lu, Indianapolis, IN US
Patent application number | Description | Published |
---|---|---|
20090222498 | SYSTEM AND METHOD FOR SYSTEM STATE REPLICATION - The invention generally describes a system and method for data backup and recovery, in particular for backing up an entire server (i.e., system state and data) in substantially real-time. The invention provides high availability by failing a source server over to a target server if the source server fails, where the target server is reconfigured nearly identically to the source server. The invention does not require the source and target servers to have identical hardware or operating system versions. The invention further allows for rapid, automatic, restoration of a source server. | 09-03-2009 |
Yeqing Lu, Notre Dame, IN US
Patent application number | Description | Published |
---|---|---|
20120032227 | LOW VOLTAGE TUNNEL FIELD-EFFECT TRANSISTOR (TFET) AND METHOD OF MAKING SAME - A low voltage tunnel field effect transistor includes a p-n tunnel junction, a gate-dielectric, a gate, a source-contact, and a drain-contact. The p-n tunnel junction includes a depletion region interfacing together a source-layer and a drain-layer. The depletion region includes a source-tunneling-region of the source-layer and a drain-tunneling-region of the drain-layer. When no external electric field is imposed, the depletion region of the p-n tunnel junction has an internal electric field that substantially points towards the source-tunneling-region and the drain-tunneling-region. The gate-dielectric is interfaced directly onto the drain-tunneling-region such that the drain-tunneling-region is between the source-tunneling-region and the gate-dielectric. The gate is interfaced onto the gate-dielectric such that the gate is configured to impose an external electric field which is oriented substantially in parallel to the internal electric field of the depletion region. | 02-09-2012 |
Yingjuan June Lu, West Lafayette, IN US
Patent application number | Description | Published |
---|---|---|
20120258905 | VITAMIN RECEPTOR DRUG DELIVERY CONJUGATES FOR TREATING INFLAMMATION - Described herein are compositions, methods, compounds, conjugates, and kits for use in targeted drug delivery using drug delivery conjugates containing hydrophilic spacer linkers for use in treating disease states caused by pathogenic cell populations, such as inflammatory cells. | 10-11-2012 |
20130203680 | FOLATE CONJUGATES FOR TREATING INFLAMMATION OF THE EYE - The present invention relates to methods of use of folate conjugates for treating inflammatory diseases of the eye, to folate conjugates for use in treating inflammatory diseases of the eye, and to folate conjugates for use in the manufacture of a medicament for treating inflammatory diseases of the eye. More particularly, the invention is directed to the use of folate linked to one or more anti-inflammatory agents for each of the above-described uses. | 08-08-2013 |